Daily Cannabis News Brief for 10/27/2026

Below is The Marijuana Herald’s Daily Cannabis News Brief for October 27, 2026, sponsored by Trulieve. The Marijuana Herald publishes a new edition every weekday at around 3 p.m. Pacific Time. Previous editions can be found by clicking here.

Federal Appeals Court Orders Reconsideration of Gun Plea Following Supreme Court Marijuana Ruling

The U.S. Court of Appeals for the 11th Circuit has ordered a lower court to reconsider a man’s request to withdraw his guilty plea for possessing firearms while using controlled substances. The decision cites the Supreme Court’s June ruling that regular marijuana use alone does not automatically justify stripping someone of their Second Amendment rights.

New Kansas Poll Finds 61% Support Legalizing and Taxing Recreational Cannabis

A new statewide survey conducted by Fort Hays State University finds that 60.9% of Kansas adults support legalizing recreational marijuana for adults 21 and older and taxing its sales. The survey also found 65% support medical marijuana legalization and 58.3% support recreational legalization when taxation is not mentioned.

Study Finds Medical Cannabis Associated With Sustained Sleep Improvements Over Two Years

A study involving 211 patients in the United Kingdom found that prescribed medical marijuana was associated with significant improvements in sleep quality lasting up to two years. Patients receiving marijuana flower had nearly five times greater odds of meaningful sleep improvement compared to those receiving marijuana oil alone.

Boston Opens Six Government Contract Opportunities to Support Marijuana Equity Businesses

Boston has opened six government contracting opportunities to provide financial, legal, architectural, engineering, marketing and business consulting assistance to marijuana businesses participating in the city’s equity program. Qualified service providers have until noon Eastern Time on December 1 to submit proposals.

Study: Newly Identified Cannabis Compound Reduces Breast Tumor Growth and Enhances Effectiveness of Tamoxifen

Researchers from Israel and Germany have identified a previously uncharacterized compound in cannabis that reduced breast cancer tumor growth in mice and enhanced the effectiveness of tamoxifen, a widely prescribed breast cancer medication. The cannabinoid, designated 373.15b, showed potential for improving treatment of estrogen receptor-positive breast cancer.

Governor Hochul Highlights New York Marijuana Industry’s Growth, With 744 Adult-Use Dispensaries Open and $4.1 Billion in Total Sales

Governor Kathy Hochul highlighted New York’s growing legal marijuana industry Tuesday, announcing that cumulative retail sales have surpassed $4.1 billion, including more than $1.4 billion during the first nine months of 2026. The state now has 744 operating adult-use dispensaries, more than 1,000 retail licenses issued and 2,351 marijuana business licenses awarded across the industry.

University of Mississippi Researchers Develop New Dissolving Microneedles for CBD Delivery

University of Mississippi researchers have developed dissolving microneedles designed to deliver cannabidiol (CBD) through the skin, using a solvent-free manufacturing process that allows high cannabinoid loading. Presented Tuesday at the American Association of Pharmaceutical Scientists’ PharmSci 360 conference, the research found approximately 70% of the CBD was released within two hours during laboratory testing.

Federally Funded Study of 864,616 Marijuana Sales Finds 1% Drop in Marijuana Prices Leads to 2.3% Increase in Sales

A federally funded study examining 864,616 marijuana product-level sales observations across 10 states found that a 1% reduction in flower prices was associated with a 2.29% increase in the amount purchased. Conducted by researchers at the University of California San Diego, the analysis highlights how strongly consumers in legal marijuana markets respond to changing prices.

South Dakota Finalizes 35 Medical Marijuana Rule Changes, Including Revised Penalties, Effective November 5

South Dakota has finalized 35 changes to its medical marijuana regulations, effective November 5. The revisions address business penalties, product testing, security and operational requirements. Under the updated penalty structure, licensed businesses committing certain lower-level violations for the first time would be allowed to submit corrective action plans instead of immediately receiving fines.

Schizophrenia Study Finds No Significant Differences in Brain Connectivity Between Marijuana Users and Nonusers

A brain-imaging study involving 51 people diagnosed with schizophrenia found no statistically significant differences in examined brain connectivity patterns between marijuana users and nonusers. Researchers also found that the ratio of THC to CBD was not significantly associated with the examined connectivity patterns or the severity of formal thought disorder.

29 Cannabis and Cannabinoid Clinical Trials Recruiting Participants in the United States, Including How to Apply

Universities, hospitals and research institutions across the United States are actively recruiting participants for 29 clinical trials involving marijuana and cannabinoids. The studies examine conditions including chronic pain, insomnia, cancer-related symptoms, epilepsy and autism, with the article detailing eligibility requirements and providing application links or contact information for each trial.

Study Finds Hemp Waste Can Be Converted Into Materials That Support Human Stem Cell Growth

Researchers have developed biodegradable hydrogels from discarded hemp stems that successfully supported human stem cell growth, suggesting potential applications in regenerative medicine, tissue engineering and wound care. The hemp-derived materials demonstrated approximately 78% porosity, substantial water absorption and cell viability exceeding 80% throughout seven days of testing.